Replimune Group, Inc.
REPLNASDAQHealthcare● Active
$8.81
$-0.66(-6.97%)
Market Cap$727464773
P/E Ratio—
52W High$13.24
52W Low$1.5
Replimune Group, Inc.（REPL）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · REPL · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B | ($0.00B) | ($0.00B) |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.19B | $0.17B | $0.13B | $0.08B | $0.06B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.26B | $0.23B | $0.18B | $0.12B | $0.08B |
| Operating Income | ($0.26B) | ($0.23B) | ($0.18B) | ($0.12B) | ($0.08B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.02B | $0.02B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.25B) | ($0.22B) | ($0.17B) | ($0.12B) | ($0.08B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | ($0.00B) | ($0.00B) |
| Net Income | ($0.25B) | ($0.22B) | ($0.17B) | ($0.12B) | ($0.08B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.07 | $-3.24 | $-2.99 | $-2.26 | $-1.75 |
| Wtd Avg Shares | 0.08B | 0.07B | 0.06B | 0.05B | 0.05B |
| EBITDA | ($0.25B) | ($0.23B) | ($0.17B) | ($0.11B) | ($0.08B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Replimune Group, Inc.
关于Replimune Group, Inc.（REPL）损益表
Replimune Group, Inc.（REPL）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，REPL实现营收$0.00B，毛利润$0.00B（毛利率—），净利润($0.25B)（净利率—）。
常见问题
REPL · 4 问Replimune Group, Inc.（REPL）2025财年营收为$0.00B，同比down—%。
REPL revenueREPL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08